Sort
15,842 grants matching “pancreatic cancer”
Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence
$395,145Veronica Wendy Setiawan · University Of Southern California · R01 · FY2017 · CA
Project 4 :Using TME genetics and immunobiology to drive combination immunotherapies
$395,115Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2019 · CA
Project 4 :Using TME genetics and immunobiology to drive combination immunotherapies
$395,115Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2022 · CA
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
$395,064Kenneth P Olive · Columbia University Health Sciences · R01 · FY2018 · CA
ALLOGENIC PANCREATIC TUMOR VACCINE CELL LINE
$395,000Johns Hopkins University · R01 · FY2002 · CA
A novel dual-carrier ultrasmall nanomedicine for the treatment of stroma-rich pancreatic cancer
$394,967Katherine Marie Eichinger · Duo Oncology Inc · R41 · FY2023 · CA
Targeting the cytokine circuitry of KRAS-driven lung cancer
$394,956David A Barbie · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Biomolecular Recognition and Binding Mechanisms
$394,923Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Discovering Spatial Mechanisms Regulating Metastatic Invadopodia in PDAC
$394,896Richard L. Klemke · University Of California, San Diego · R01 · FY2021 · CA
Mechanochemical Effects on Tumor Cell Signaling, Adhersion and Migration
$394,799Konstantinos Konstantopoulos · Johns Hopkins University · U54 · FY2013 · CA
Development of Claudin MAbs for Treating Solid Tumors
$394,721Joseph Benjamin Rucker · Integral Molecular · R44 · FY2024 · CA
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology
$394,579Gerard C Blobe · Duke University · R01 · FY2023 · CA
Targeting the cytokine circuitry of KRAS-driven lung cancer
$394,578David A Barbie · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Targeting the cytokine circuitry of KRAS-driven lung cancer
$394,578David A Barbie · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Targeting the cytokine circuitry of KRAS-driven lung cancer
$394,578David A Barbie · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
$394,548Edwin Manuel · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Exploring the epigenetic control of pancreatic cancer subtypes
$394,548Sita Kugel · Fred Hutchinson Cancer Center · R37 · FY2023 · CA
Targeting CXCR2 axis in Pancreatic Cancer
$394,508Rakesh K Singh · University Of Nebraska Medical Center · R01 · FY2022 · CA
Theranostic nanoparticles for detection and treatment of pancreatic cancer
$394,421Lacey R McNally · Wake Forest University Health Sciences · R01 · FY2017 · EB
Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach
$394,420Stephen K. Van Den Eeden · Kaiser Foundation Research Institute · U01 · FY2018 · DK
The Development of Clinical Grade, Targeted Magnetic Nanoparticles
$394,353Ralph Weissleder · Massachusetts Institute Of Technology · U54 · FY2013 · CA
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$394,322Gauri Varadhachary · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer
$394,220Walter Gwang-Up Park · Stanford University · U01 · FY2015 · DK
(PQD6) Muscle stem cells and cancer cachexia
$394,097Denis C Guttridge · Ohio State University · R01 · FY2016 · CA
Precision Management of Cystic Precursors to Pancreatic Cancer
$394,049Pari Vijay Pandharipande · Ohio State University · R01 · FY2024 · CA